Skip to main content
padlock icon - secure page this page is secure

Publisher: Wiley-Blackwell

Volume 95, Number 4, 1 October 2015

Molecular deregulation of signaling in lymphoid tumors
pp. 257-269(13)
Authors: Spina, Valeria; Martuscelli, Lavinia; Rossi, Davide

Favourites:
ADD

Molecular diagnostics of myeloproliferative neoplasms
pp. 270-279(10)
Authors: Langabeer, Stephen E.; Andrikovics, Hajnalka; Asp, Julia; Bellosillo, Beatriz; Carillo, Serge; Haslam, Karl; Kjaer, Lasse; Lippert, Eric; Mansier, Olivier; Oppliger Leibundgut, Elisabeth; Percy, Melanie J.; Porret, Naomi; Palmqvist, Lars; Schwarz, Jiri; McMullin, Mary F.; Schnittger, Susanne; Pallisgaard, Niels; Hermouet, Sylvie; -cr, the MPN&MPNr‐EuroNetejh1

Favourites:
ADD

The molecular pathogenesis of B‐cell non‐Hodgkin lymphoma
pp. 280-293(14)
Authors: Blombery, Piers A.; Wall, Meaghan; Seymour, John F.

Favourites:
ADD

Familial thrombotic risk based on the genetic background of Protein C Deficiency in a Portuguese Study
pp. 294-307(14)
Authors: Fidalgo, Teresa; Martinho, Patrícia; Salvado, Ramon; Manco, Licínio; Oliveira, Ana C.; Pinto, Catarina S.; Gonçalves, Elsa; Marques, Dalila; Sevivas, Teresa; Martins, Natália; Ribeiro, Maria Letícia

Favourites:
ADD

Immunophenotypic analysis of hematopoiesis in patients suffering from Shwachman–Bodian–Diamond Syndrome
pp. 308-315(8)
Authors: Mercuri, Angela; Cannata, Elisa; Perbellini, Omar; Cugno, Chiara; Balter, Rita; Zaccaron, Ada; Tridello, Gloria; Pizzolo, Giovanni; De Bortoli, Massimiliano; Krampera, Mauro; Cipolli, Marco; Cesaro, Simone

Favourites:
ADD

Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation
pp. 316-324(9)
Authors: Scheid, Christof; Reece, Donna; Beksac, Meral; Spencer, Andrew; Callander, Natalie; Sonneveld, Pieter; Kalimi, Ghulam; Cai, Can; Shi, Michael; Scott, Jeffrey W.; Stewart, A. Keith

Favourites:
ADD

Efficacy and safety of low‐dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome
pp. 325-330(6)
Authors: Cai, Qian‐Qian; Wang, Chen; Cao, Xin‐Xin; Cai, Hao; Zhou, Dao‐Bin; Li, Jian

Favourites:
ADD

Dose‐adjusted arsenic trioxide for acute promyelocytic leukaemia in chronic renal failure
pp. 331-335(5)
Authors: Firkin, Frank; Roncolato, Fernando; Ho, Wai Khoon

Favourites:
ADD

Self‐reported activity and functioning in daily life; the perspective of persons with haemophilia living in Sweden
pp. 336-341(6)
Authors: Brodin, Elisabeth; Baghaei, Fariba; Sunnerhagen, Katharina S.

Favourites:
ADD

Evaluation of bone involvement in patients with Gaucher disease: a semi‐quantitative magnetic resonance imaging method (using ROI estimation of bone lesion) as an alternative method to semi‐quantitative methods used so far
pp. 342-351(10)
Authors: Komninaka, Veroniki; Kolomodi, Dionysia; Christoulas, Dimitrios; Marinakis, Theodoros; Papatheodorou, Athanasios; Repa, Konstantina; Voskaridou, Ersi; Revenas, Konstantinos; Terpos, Evangelos

Favourites:
ADD

Characterization of a new human plasma cell leukemia cell line UHKT‐944
pp. 352-360(9)
Authors: Vyhlídalová, Ilona; Uherková, Lenka; Pleschnerová, Markéta; Špička, Ivan; Březinová, Jana; Michalová, Kyra; Čermáková, Kamila; Polanská, Veronika; Jedelský, Petr L.; Hamšíková, Eva; Kuželová, Kateřina; Stöckbauer, Petr

Favourites:
ADD

Brentuximab vedotin desensitization in a patient with refractory Hodgkin's lymphoma
pp. 361-364(4)
Authors: Arora, Anubha; Bhatt, Vijaya Raj; Liewer, Susanne; Armitage, James O.; Bociek, R. Gregory

Favourites:
ADD

Leukemia diagnosis: today and tomorrow
pp. 365-373(9)
Authors: Béné, Marie C.; Grimwade, David; Haferlach, Claudia; Haferlach, Torsten; Zini, Gina; the European LeukemiaNetejh12603-cr-0006

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more